Choices and Experiences Around Closed-loop Therapy in Type 1 Diabetes

Type 1 diabetes requires a lot of work to try to keep glucose levels in the target range. Hybrid closed- loop, also known as artificial pancreas, takes glucose readings from a sensor (continuous glucose monitor) and uses an algorithm to tell an insulin pump how much insulin to deliver. Hybrid closed-loop has currently been rolled out to many people with type 1 diabetes in England. We are keen to develop a deeper understanding of the perspective of people living with type 1 diabetes who have choices about which hybrid closed-loop systems fit their needs. The main purpose of this study is to explore the choices and experiences of people living with type 1 diabetes regarding closed-loop therapy.

NCT Number	NCT07177404
Lead Sponsor	University of Nottingham
Conditions	Diabete Mellitus, Type 1 Diabetes Mellitus
Enrollment	166 participants
Start Date	2025-09-04
Primary Completion	2026-02-26 (estimated)
Study Completion	2026-02-26 (estimated)
Updated on ClinicalTrials.gov	2026-04-29